EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

EBV Reactivation and Disease in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients and Its Impact on HSCT Outcomes

Nancy Law iD, Cathy Logan iD, Randy Taplitz iD

Viruses · 2024

DOI: 10.3390/v16081294 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, 2024. Verfasst von Nancy Law und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California, La Jolla, CA 92093, USA. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Epstein-Barr Virus Infections, Herpesvirus 4, Human, Virus Activation. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The acquisition or reactivation of Epstein–Barr virus (EBV) after allogeneic Hematopoietic Stem Cell Transplant (HSCT) can be associated with complications including the development of post-transplant lymphoproliferative disorder (PTLD), which is associated with significant morbidity and mortality. A number of risk factors for PTLD have been defined, including T-cell depletion, and approaches to monitoring EBV, especially in high-risk patients, with the use of preemptive therapy upon viral activation have been described. Newer therapies for the preemption or treatment of PTLD, such as EBV-specific cytotoxic T-cells, hold promise. Further studies to help define risks, diagnosis, and treatment of EBV-related complications are needed in this at-risk population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationEpstein-Barr Virus InfectionsHerpesvirus 4, HumanVirus ActivationTransplantation, HomologousLymphoproliferative DisordersHumansRisk Factors

Stichwörter der Autor:innen

EBV-specific cytotoxic T-cellsEpstein–Barr virusallogeneic transplantpost-transplant lymphoproliferative disorder

Autor:innen und Institutionen

  • Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California, La Jolla, CA 92093, USA.
  • Division of Infectious Diseases, Department of Medicine, City of Hope National Medical Center, Duarte, CA 91010, USA.

ORCID-Profile: Nancy Law, Cathy Logan, Randy Taplitz

Zitieren

APA

Law, N., Logan, C., & Taplitz, R. (2024). EBV Reactivation and Disease in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients and Its Impact on HSCT Outcomes. Viruses. https://doi.org/10.3390/v16081294

Vancouver

Law N, Logan C, Taplitz R. EBV Reactivation and Disease in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients and Its Impact on HSCT Outcomes. Viruses. 2024. doi:10.3390/v16081294

BibTeX
@article{Law2024,
  author = {Law, Nancy and Logan, Cathy and Taplitz, Randy},
  title = {EBV Reactivation and Disease in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients and Its Impact on HSCT Outcomes},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16081294}
}
Kostenlos starten →